@dansfera: The industry has been trying to automate site owners out of existence for years, but one expert is here to remind everyone why that’s easier said than done. Flashback to 2019: remember the big promise of virtual clinical trials and the prediction that decentralized models would replace traditional site operations? It never quite took off, and there is a very specific reason why. Clinical trials are inherently complex, and replacing the human element on the ground is a massive challenge. A crucial reality check for anyone wondering if AI or new tech will truly render the site owner obsolete. #clinicaltrials #siteowner #biotech #clinicalresearch #industryinsights